Rationale, aims, and objectives: The practice of glycaemic control of critically ill patients admitted to intensive care units (ICUs) is guided by clinical management protocols, designed locally by the ICUs. These protocols differ significantly in their aims and methods. The aim of this study was to develop a standardized methodology for the systematic and objective analysis and comparison of protocols for glycaemic control implemented in any ICU.
| INTRODUCTION
Hyperglycaemia, hypoglycaemia, and increased glycaemic variability are three domains of glycaemic control that have been associated with higher risks of poor outcomes in critically ill patients, including impaired wound healing, neuro-myopathy, sepsis, multiple organ failure, cardiac dysfunction, and mortality. 1 Currently, available evidence about ideal glycaemic target ranges, and the safest and most effective methods of glycaemic control to achieve these in intensive care units (ICUs), is discrepant and conflicting. [2] [3] [4] [5] [6] This is a crucial barrier to the development of common quality standards for glycaemic control of the critically ill.
Thus, the recommendations of existing national and international guidelines on glycaemic control in the ICU differ among each other. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] As a consequence of the discrepant evidence and the lack of common guidelines and standards about the management of dysglycaemias in intensive care, ICUs implement their own locally developed clinical management protocols for glycaemic control. [19] [20] [21] [22] [23] [24] [25] Clinical management protocols have been defined as documents that "provide advice to decide about what clinical diagnostic and treatment steps should be taken (…)", including "(…) documents relating only to drug doses and prescription timing for the treatment of specific medical conditions". 26 For ease of reading, these will be referred to as protocols.
Numerous studies have been carried out comparing the effectiveness of local protocols for glycaemic control, [27] [28] [29] [30] but these studies usually lack the fundamental previous step of describing and comparing in detail the characteristics and instructions of the protocols under comparison. The few reported studies describing and comparing different protocols for glycaemic control found important variances between them. 20, 23 However, these studies either dealt with general descriptions of the protocols' instructions, or they focused mainly on the protocols' insulin algorithms. There is a lack of studies that report detailed descriptions and comparisons of each of the protocols' instructions for the management of different glycaemic ranges. This is possibly due to the lack of a standardized, replicable, and globally transferable method, which allows for systematic descriptions and comparisons of the contents of ICU protocols for glycaemic control, and which would make these analyses comprehensive and comparable across hospitals and internationally.
The aim of this study was to develop a specific methodology for the systematic quantitative and qualitative description and comparison of the contents of protocols for glycaemic control. The aim was for this methodology to be comprehensive, as well as flexible, so that it could be used in any future studies requiring or aiming to describe and compare such protocols. This was part of a larger study, known as GlyCon, carried out within seven ICUs of the Mid Trent Critical Care Network (MTCCN).
| METHODS

| Sample of protocols
The MTCCN is a critical care network of ICUs in the UK that aims to provide common standards of care and protocols to all critically ill patients admitted within the geographical area that it covers. 31 The MTCCN's Service Improvement Group encourages and facilitates the sharing of local policies, procedures, and guidelines among the staff of its ICUs, 32 and accepted GlyCon as a proposed study for the group.
The seven ICUs of the MTCCN that admit patients with the highest levels of care needs (requiring either advanced respiratory support alone or support for a minimum of two organs), accepted to participate in GlyCon study.
Soft copies of the protocols for glycaemic control, which had been in place in the seven participating ICUs during the study period (2012-2013), were acquired from each of the units through the study's local collaborators. In this study, the protocols for glycaemic control were the sources of information, whereas data were to be collected from the contents of these protocols.
| Data collection and analyses
Data were collected (extracted from the protocols) through open coding (labelling) of the protocols' content as described by Elo and Kyngäs. 33 This allowed categories of data to emerge directly from the textual information, 34, 35 ie, to be inferred inductively. Through this procedure, codes (labels) were first assigned to the selected initial units of analysis. These were each of the text sentences, or clauses within sentences, written in the protocols. The codes were grouped into broader categories, and these codes and inferred categories were used to label subsequent units of analysis. Using the framework method, 36 summarized data were included (charted) into a matrix of codes (columns) and protocols (rows). A final set of categories of data or subjects, which may be present in a protocol, was abstracted through systematic comparisons of the charted data across protocols.
These were used to develop a framework to guide the description and comparison of the contents of protocols for glycaemic control.
A technique for condensing protocol instructions within a single detailed flowchart, and a method for assessing the complexity and comprehensiveness of the protocols using such flowcharts, were proposed. Details about this technique are described in the results section, as this was a newly developed method and, therefore, an outcome of this study. For this method, a distinction was made between "processes," "decisions," and "scenarios. 
| Ethical considerations
This study did not involve human subjects. The study had sponsorship 
| RESULTS
The outcomes of this study included: (1) the array of "categories"
that emerged from the analysis and, based on these, a list of quantifiable "variables" (Table 1 ) and a list of non-quantifiable "subjects"
( Table 2 ) that can be present in protocols for glycaemic control; (2) a technique for condensing a protocol into a single, comprehensive flowchart ( Figure 1 ); and (3) using the flowchart, a method for assessing the complexity and completeness of the protocols ( Figure 2 and Table 3 ).
| Protocol categories, variables, and subjects
The two broadest categories of data identified in the protocols were:
1) The method used for the protocol development. This category included metadata about when, how, and by whom the protocol 
Is there a hyperglycaemic threshold instructing to inform medical staff?
Hyperglycaemic threshold indicating when to inform medical staff
Is there a hypoglycaemic threshold instructing to inform medical staff?
Hypoglycaemic threshold indicating when to inform medical staff
Hypoglycaemic threshold indicating the administration of rescue glucose [b] Severe hypoglycaemia defined as random blood glucose ≤2.2 mmol/L or symptomatic hypoglycaemia.
[c] Blood gas analyser/glucose meter/laboratory/not mentioned.
[d] Arterial/venous/capillary/not mentioned.
[e] Fast-acting / fast-acting + basal / other / not mentioned.
[f] Intravenous/subcutaneous/both intravenous and subcutaneous accepted/not mentioned.
[g] Fixed rates / adjustments of previous rates / both fixed rates and adjustments of previous rates / not mentioned.
[h] Different IIR/different TNM/only mentioned as an aspect that should be considered/not mentioned.
[ was developed, as well as the evidence on which the protocol was based, and for which target patients it was meant to be used.
These could be either quantifiable characteristics or non-quantifiable features of the protocols.
2) The protocol instructions for glycaemic control. This category b) The glycaemic status to which the instruction referred. Depending on this status, four further "sub-categories" were distinguished, namely instructions relevant to glycaemic levels below, within or above the protocol's glycaemic target range, as well as instructions that were relevant at all glycaemic levels.
c) The quantifiable nature of the instruction. Based on this, instructions could be classified as either quantifiable data (instructions that could be counted or transformed into categorical variables) or non-quantifiable information.
These categories of protocol instructions were used to create the list of quantifiable variables (Table 1 , 35 variables in total) and the list of non-quantifiable subjects ( Table 2 , 11 subjects in total).
| Protocol flowcharts and scenarios
The proposed method to design protocol flowcharts, and describe them, includes the steps enumerated below. An example of how this would be done is illustrated in Figures 1 and 2. 1) Identify each of the glycaemic ranges considered by the protocol.
2) Identify all the instructions dealing with each of these glycaemic ranges, for any given glycaemic measurement, and classify them as either a process or a decision (as defined in the Methods section).
3) Depict these processes and decisions schematically in closedloop flowcharts, in a way that each loop (scenario) starts and finishes with a glycaemic measurement (Figures 1 and 2 ). Processes should be represented with a rectangle, decisions with a diamond, and outputs or data (such as glycaemic levels) with a parallelogram, following the International Organization for Standardization (ISO) 5807 standard. 37 An example of the resulting flowchart for one of the protocols included in GlyCon study is included in Figure 1. 4) Identify and count all glycaemic ranges considered by the flowchart.
5) Identify and count all scenarios considered by the flowchart. [c] Insulin type classified based on how quickly they work, when they reach their highest levels in blood, and how long they last. Table 3 with metrics about the above counts (totals, medians, and ranges), and with the types of processes and decisions considered by the flowcharts.
The metrics in Table 3 can be used to describe the number and types of scenarios, and processes and decisions interacting within each scenario. This may then be used to compare the complexity and comprehensiveness of different protocols for glycaemic control.
Data from Tables 1 and 2 complement Table 3 for such descriptions. In this respect, it is useful to note that Grol et al 38 described an instruction or recommendation as complex when it is composed of numerous different interacting elements, and includes a complex decision tree, besides other factors that could affect these elements. Therefore, the set of tools developed in GlyCon will facilitate the performance of future studies exploring the practice of glycaemic control in ICU and will increase the comparability and transferability of such reports. These investigations are crucial to enable clinicians and researchers have a better understanding about how dysglycaemias in the critically ill are currently being managed within the ICU, whether at the institutional, regional, or international levels. Moreover, exploring the recommendations that guide the methods for glycaemic control implemented in the ICU should be an essential first step of any study looking at the impact of such methods, including their effectiveness, efficiency, and safety.
| CONCLUSIONS
Future work analysing and comparing the contents of local protocols for glycaemic control in ICU is essential to enable the clinical and scientific communities understand how dysglycaemic events are currently being managed in intensive care. Furthermore, these studies should be a fundamental initial step of any impact (outcome) evaluation of these protocols. The proposed methodology, developed as part of GlyCon study, will allow for such future work to be carried out in a standardized and comparable way. In turn, this will facilitate the performance of national and international comparisons, demonstrating the usefulness of this study at a global scale. 
